|

US: Sluggish demand and lack of demand pull price inflation - Rabobank

Jane Foley, Senior FX Strategist at Rabobank, notes that earlier this month Fed Vice-Chair Fischer delivered a speech in which he explained several of the factors that are depressing the level of interest rates that is required for the Fed to meet its dual policy mandate.

Key Quotes

“Among these factors are the ageing demographic and the impact of this on pushing up household savings and leading to slackening demand. Slow growth in productivity, soft levels of investment and a slowing in the pace of growth overseas are also cited. The majority of these factors are common to other developed world economies. They are also outside of the control of central banks and many are likely to bear down on the equilibrium interest rate for years to come.

The lack of growth in productivity may be common to many developed economies, but there is still a lack of consensus as to the causes and the solutions to the problem. Fischer refers to the slower pace of innovation creating fewer investment opportunities. Others blame the low interest rate environment for keeping alive zombie companies and undermining the capitalist notion of creative destruction which could bring higher productivity growth albeit with the cost of higher unemployment.

Recently there has been a rise on pressure on some governments to invest in infrastructure in order to raise productivity and growth potential. That said, for many countries high levels of government debt remains a constraint. Without a solution low productivity growth will continue to reduce the future income stream for households and have a depressive impact on consumption spending. The result is sluggish demand and lack of demand pull price inflation. The consequence of this is a persistently low level of equilibrium interest rates from central banks.”

Author

Sandeep Kanihama

Sandeep Kanihama

FXStreet Contributor

Sandeep Kanihama is an FX Editor and Analyst with FXstreet having principally focus area on Asia and European markets with commodity, currency and equities coverage. He is stationed in the Indian capital city of Delhi.

More from Sandeep Kanihama
Share:

Editor's Picks

EUR/USD struggles to hold above 1.1800 ahead of US data

EUR/USD finds it difficult to gather recovery momentum and retreats below 1.1800 in the second half of the day on Thursday. The US Dollar (USD) stays resilient against its peers after the hawkish surprise in FOMC Minutes, weighing on the pair ahead of the next batch of US data.

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold retreats from daily highs, trades below $5,000

Gold finds it difficult to stabilize above the $5,000 psychological mark on Thursday and trades slightly below this level in the early American session. Escalating geopolitical tensions in the Middle East help XAU/USD hold its ground, while the broad-based USD strength caps the pair's upside.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.